Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,028 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $893.15 | 64 | $0 (2024) |
| Lilly USA, LLC | $265.73 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $244.66 | 12 | $0 (2024) |
| Edwards Lifesciences Corporation | $104.81 | 1 | $0 (2017) |
| Corium, LLC | $99.07 | 4 | $0 (2024) |
| PFIZER INC. | $84.83 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $80.66 | 2 | $0 (2022) |
| Amgen Inc. | $78.86 | 4 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $31.44 | 2 | $0 (2021) |
| Exact Sciences Corporation | $29.07 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $805.92 | 44 | ABBVIE INC. ($292.89) |
| 2023 | $496.31 | 33 | ABBVIE INC. ($303.69) |
| 2022 | $470.53 | 34 | ABBVIE INC. ($296.57) |
| 2021 | $60.06 | 4 | Supernus Pharmaceuticals, Inc. ($31.44) |
| 2018 | $65.00 | 1 | GlaxoSmithKline, LLC. ($65.00) |
| 2017 | $130.39 | 3 | Edwards Lifesciences Corporation ($104.81) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Neuromodulation | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: VACCINES | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardio-renal | ||||||
| 04/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,378 | 1,990 | $387,143 | $81,767 |
| 2022 | 21 | 1,509 | 2,064 | $370,920 | $78,806 |
| 2021 | 15 | 2,310 | 2,648 | $304,028 | $113,617 |
| 2020 | 5 | 683 | 1,200 | $121,900 | $26,098 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 764 | $188,708 | $31,085 | 16.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 155 | 162 | $30,780 | $11,609 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 278 | $48,372 | $10,376 | 21.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 54 | 54 | $15,552 | $6,938 | 44.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 160 | 168 | $6,720 | $4,818 | 71.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $7,950 | $4,239 | 53.3% |
| 77067 | Screening mammography | Office | 2023 | 36 | 36 | $6,156 | $2,895 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 227 | 227 | $56,977 | $2,490 | 4.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 54 | 54 | $4,860 | $2,066 | 42.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 21 | $3,150 | $727.02 | 23.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 19 | 19 | $1,710 | $726.75 | 42.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 49 | 57 | $3,534 | $708.76 | 20.1% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 33 | 33 | $1,617 | $690.33 | 42.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 23 | 23 | $1,817 | $581.21 | 32.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $5,835 | $564.00 | 9.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $544.00 | $487.56 | 89.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 22 | 26 | $1,664 | $410.24 | 24.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 16 | 21 | $1,197 | $357.28 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 739 | $182,533 | $30,792 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 256 | $44,544 | $9,829 | 22.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 129 | 130 | $24,700 | $8,907 | 36.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 124 | 124 | $11,160 | $4,453 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 241 | 241 | $60,491 | $4,417 | 7.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 150 | 153 | $4,896 | $4,159 | 84.9% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 96 | 97 | $8,730 | $3,509 | 40.2% |
About Dr. Jeremy Holter, MD
Dr. Jeremy Holter, MD is a Internal Medicine healthcare provider based in Shawnee, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003859778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremy Holter, MD has received a total of $2,028 in payments from pharmaceutical and medical device companies, with $805.92 received in 2024. These payments were reported across 119 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,028).
As a Medicare-enrolled provider, Holter has provided services to 5,880 Medicare beneficiaries, totaling 7,902 services with total Medicare billing of $300,288. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Shawnee, OK
- Active Since 06/13/2006
- Last Updated 08/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003859778
Products in Payments
- VRAYLAR (Drug) $419.67
- QULIPTA (Drug) $339.70
- MOUNJARO (Drug) $153.44
- AIRSUPRA (Drug) $151.16
- UBRELVY (Drug) $133.15
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $104.81
- BREZTRI (Drug) $93.50
- SHINGRIX (Biological) $80.66
- Otezla (Drug) $78.86
- JARDIANCE (Drug) $73.20
- Azstarys (Drug) $59.08
- TRULICITY (Drug) $54.60
- AZSTARYS (Drug) $39.99
- QELBREE (Drug) $31.44
- Cologuard Collection Kit (Device) $29.07
- XYOSTED (Drug) $21.29
- ELIQUIS (Drug) $21.03
- NURTEC ODT (Drug) $19.27
- PREVNAR 20 (Biological) $18.95
- REXULTI (Drug) $18.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shawnee
Dr. Isma Javed, M.d, M.D
Internal Medicine — Payments: $14,621
Dr. Kelli Koons, M.d, M.D
Internal Medicine — Payments: $1,847
James Allen, Md, MD
Internal Medicine — Payments: $1,454
Dr. Phillip Haddad, M.d, M.D
Internal Medicine — Payments: $1,418
Danielle Stebbins, Md, MD
Internal Medicine — Payments: $1,237
Amber Niewald, Md, MD
Internal Medicine — Payments: $838.72